Prothrombotic Gene polymorphisms: Possible contributors to hepatic artery thrombosis after orthotopic liver transplantation

Transplantation

Volumn 92, Issue 5, 2011, Pages 587-593

  Pereboom, Ilona T A ^a,b   Adelmeijer, Jelle ^b   Van Der Steege, Gerrit ^a   Van Den Berg, Aad P ^a   Lisman, Ton ^a,b   Porte, Robert J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Factor V Leiden; Gene polymorphism; Hepatic artery thrombosis; Liver transplantation; Thrombosis

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ALPHA2 INTEGRIN; BETA3 INTEGRIN; BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 5 LEIDEN; GENOMIC DNA; PROTHROMBIN; THROMBOSPONDIN; THROMBOSPONDIN 4; UNCLASSIFIED DRUG;

ADULT; ARTERY THROMBOSIS; ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEPATIC ARTERY; HEPATIC ARTERY THROMBOSIS; HETEROZYGOTE; HUMAN; LIVER TRANSPLANTATION; LIVER VEIN THROMBOSIS; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL;

ADULT; COHORT STUDIES; FACTOR V; FACTOR XIII; FEMALE; HEPATIC ARTERY; HUMANS; INTEGRIN ALPHA2; INTEGRIN BETA3; LIVER TRANSPLANTATION; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; POLYMORPHISM, GENETIC; PROTHROMBIN; RISK FACTORS; THROMBOSIS; THROMBOSPONDINS; TISSUE DONORS;

EID: 81155161045     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318228063b     Document Type: Article

References (32)

1. Bell R, Sheil AG, Thompson JF, et al. Vascular complications following orthotopic liver transplantation. Aust N Z J Surg 1990; 60: 193.
2. Pfitzmann R, Nussler NC, Hippler-Benscheidt M, et al. Long-term results after liver transplantation. Transpl Int 2008; 21: 234.
3. Silva MA, Jambulingam PS, Gunson BK, et al. Hepatic artery thrombosis following orthotopic liver transplantation: A 10-year experience from a single centre in the United Kingdom. Liver Transpl 2006; 12: 146.
4. Stange BJ, Glanemann M, Nuessler NC, et al. Hepatic artery thrombosis after adult liver transplantation. Liver Transpl 2003; 9: 612.
5. Lisman T, Porte RJ. Hepatic artery thrombosis after liver transplantation: More than just a surgical complication? Transpl Int 2009; 22: 162.
6. Mas VR, Fisher RA, Maluf DG, et al. Hepatic artery thrombosis after liver transplantation and genetic factors: Prothrombin G20210A polymorphism. Transplantation 2003; 76: 247.
7. Bispo M, Marcelino P, Freire A, et al. High incidence of thrombotic complications early after liver transplantation for familial amyloidotic polyneuropathy. Transpl Int 2009; 22: 165.
8. Bertina RM, Koeleman BP, Koster T, et al. Mutation in blood coagulation factorVassociated with resistance to activated protein C. Nature 1994; 369: 64.
9. Poort SR, Rosendaal FR, Reitsma PH, et al. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698.
10. Dunn TB, Linden MA, Vercellotti GM, et al. Factor V Leiden and hepatic artery thrombosis after liver transplantation. Clin Transplant 2006; 20: 132.
11. Leroy-Matheron C, Duvoux C, Van Nhieu JT, et al. Activated proteinC resistance acquired through liver transplantation and associated with recurrent venous thrombosis. J Hepatol 2003; 38: 866.
12. Tanyel FC, Ocal T, Balkanci F, et al. The factor V Leiden mutation: A possible contributor to the hepatic artery thrombosis encountered after liver transplantation in a child. J Pediatr Surg 2000; 35: 607.
13. Hirshfield G, Collier JD, Brown K, et al. Donor factor V Leiden mutation and vascular thrombosis following liver transplantation. Liver Transpl Surg 1998; 4: 58.
14. Akoglu B, Kindl P, Weber N, et al. Polymorphisms in the methylenetetrahydrofolate reductase gene are determinant for vascular complications after liver transplantation. Eur J Clin Nutr 2008; 62: 430.
15. Ariens RA, Lai TS, Weisel JW, et al. Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms. Blood 2002; 100: 743.
16. Den Heijer HM, Lewington S, Clarke R. Homocysteine, MTHFR and risk of venous thrombosis: A meta-analysis of published epidemiological studies. J Thromb Haemost 2005; 3: 292.
17. Santoso S, Kunicki TJ, Kroll H, et al. Association of the platelet glycoprotein Ia C807T gene polymorphism with nonfatal myocardial infarction in younger patients. Blood 1999; 93: 2449.
18. Topol EJ, McCarthy J, Gabriel S, et al. Single nucleotide polymorphisms in multiple novel thrombospondin genes may be associated with familial premature myocardial infarction. Circulation 2001; 104: 2641.
19. Weiss EJ, Bray PF, Tayback M, et al. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med 1996; 334: 1090.
20. Foster PA, Varma RR. Phenotypic correction of activated protein C resistance following orthotopic liver transplantation. Blood Coagul Fibrinolysis 1996; 7: 65.
21. Schuetze SM, Linenberger M. Acquired protein S deficiency with multiple thrombotic complications after orthotopic liver transplant. Transplantation 1999; 67: 1366.
22. Prandoni P. Links between arterial and venous disease. J Intern Med 2007; 262: 341.
23. Wessel J, Topol EJ, Ji M, et al. Replication of the association between the thrombospondin-4 A387P polymorphism and myocardial infarction. Am Heart J 2004; 147: 905.
24. Ye Z, Liu EH, Higgins JP, et al. Seven haemostatic gene polymorphisms in coronary disease: Meta-analysis of 66,155 cases and 91,307 controls. Lancet 2006; 367: 651.
25. Lewis SJ, Ebrahim S, Davey SG. Meta-analysis of MTHFR 677C-
26. Lisman T, Bongers TN, Adelmeijer J, et al. Elevated levels of von Willebrand factor in cirrhosis support platelet adhesion despite reduced functional capacity. Hepatology 2006; 44: 53.
27. Pereboom IT, Adelmeijer J, van Leeuwen Y, et al. No evidence for systemic platelet activation during or after orthotopic liver transplantation. Liver Transpl 2009; 15: 956.
28. Pereboom IT, Adelmeijer J, van Leeuwen Y, et al. Development of a severe von Willebrand factor/ADAMTS13 dysbalance during orthotopic liver transplantation. Am J Transplant 2009; 9: 1189.
29. Vivarelli M, La Barba G, Cucchetti A, et al. Can antiplatelet prophylaxis reduce the incidence of hepatic artery thrombosis after liver transplantation? Liver Transpl 2007; 13: 651.
30. Spaggiari M, Di Benedetto F, Masetti M, et al. The impact of inherited thrombophilia on liver transplantation. Transplantation 2009; 87: 1103.
31. Gallus AS. Management options for thrombophilias. Semin Thromb Hemost 2005; 31: 118.
32. Tzakis A, Todo S, Starzl TE. Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg 1989; 210: 649.